<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: The purpose of this study was to obtain data on the association of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> with clinical manifestations in childhood and to enable future studies to determine the impact of treatment and long-term outcome of pediatric <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: A European registry extended internationally of pediatric patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> was established as a collaborative project of the European <z:hpo ids='HP_0003613'>Antiphospholipid Antibodies</z:hpo> Forum and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> Working Group of the Pediatric Rheumatology European Society </plain></SENT>
<SENT sid="2" pm="."><plain>To be eligible for enrollment the patient must meet the preliminary criteria for the classification of pediatric <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> must have occurred before the patient's 18th birthday </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: As of December 1, 2007, there were 121 confirmed <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> cases registered from 14 countries </plain></SENT>
<SENT sid="4" pm="."><plain>Fifty-six patients were male, and 65 were female, with a mean age at the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> of 10.7 years </plain></SENT>
<SENT sid="5" pm="."><plain>Sixty (49.5%) patients had underlying <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0004936'>Venous thrombosis</z:hpo> occurred in 72 (60%), <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> in 39 (32%), small-vessel <z:mp ids='MP_0005048'>thrombosis</z:mp> in 7 (6%), and mixed arterial and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> in 3 (2%) </plain></SENT>
<SENT sid="7" pm="."><plain>Associated nonthrombotic clinical manifestations included hematologic manifestations (38%), <z:e sem="disease" ids="C0037274" disease_type="Disease or Syndrome" abbrv="">skin disorders</z:e> (18%), and nonthrombotic neurologic manifestations (16%) </plain></SENT>
<SENT sid="8" pm="."><plain>Laboratory investigations revealed positive anticardiolipin antibodies in 81% of the patients, anti-beta(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibodies in 67%, and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> in 72% </plain></SENT>
<SENT sid="9" pm="."><plain>Comparisons between different subgroups revealed that patients with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> were younger and had a higher frequency of arterial thrombotic events, whereas patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> associated with underlying <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> were older and had a higher frequency of venous thrombotic events associated with hematologic and skin manifestations </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Clinical and laboratory characterization of patients with pediatric <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> implies some important differences between <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> in pediatric and adult populations </plain></SENT>
<SENT sid="11" pm="."><plain>Comparisons between children with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> associated with <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> have revealed certain differences that suggest 2 distinct subgroups </plain></SENT>
</text></document>